Will Workers’ Comp Benefit from ‘Most-Favored-Nation’ Drug Pricing? May 27, 2025 By Brian Allen Earlier this month, President Trump teased a “big announcement” was coming, touting it as “one of the most important …...
Enlyte: Migraine Medications Continue Rising in Workers’ Comp April 30, 2025 The use of migraine medications in workers’ compensation prescriptions, despite the overall cost per claim decreasing, a new report shows....
Gilead Sciences Reaches $202M Settlement Over Kickbacks to Doctors April 29, 2025 By Jonathan Stempel Gilead Sciences agreed to pay $202 million to settle a whistleblower lawsuit accusing the drugmaker of civil fraud for paying...
Walgreens to Pay $300 Million in US Opioid Settlement April 22, 2025 By Brendan Pierson and Ismail Shakil Walgreens has agreed to pay $300 million to settle U.S. prosecutors’ allegations that it illegally filled millions of invalid prescriptions...
GSK Zantac Appeal Gets Tough Questions From Some US Judges April 17, 2025 By Jef Feeley and Sabrina Willmer Some Delaware Supreme Court justices signaled they may be skeptical of a bid by GSK Plc, Pfizer Inc. and other...
Viatris to Pay $335 Million to Resolve Opioid-Related Claims April 7, 2025 By Christy Santhosh Viatris said on Monday it would pay up to $335 million over nine years as part of a nationwide settlement...
GSK Resolves Patent Lawsuit Against Pfizer Over RSV Vaccines April 4, 2025 By Blake Brittain British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer’s respiratory syncytial virus (RSV)...
A True Alternative to Opioids for Workers’ Comp? Questions Remain March 10, 2025 By Nikki Wilson Recent FDA approval of suzetrigine, representing the first new class of pain medication in more than 20 years, is generating...
J&J Sues Samsung Bioepis Over Contract Breach for Stelara Biosimilar February 25, 2025 By Sneha S K Johnson & Johnson said on Monday it had filed a lawsuit against Samsung Bioepis for breaching its contract agreement with...
Merck’s $8 Billion Cancer Vaccine Faces First US Jury Trial January 27, 2025 By Peter Blumberg Merck & Co. is facing its first jury trial over claims the company wrongfully marketed its lucrative Gardasil cancer vaccine...